Cytokines previously reported to be able to induce EG (30 (link), 31 (link)) were inhibited by injection of antibody or biological inhibitors. Anakinra [Kineret from Sobi DIN 02245913; anti-IL-1 at 25 μg/g mouse as used in (46 (link))], etanercept [Enbrel from Amgen, DIN 02242903; anti–TNF-α at 15 μg/g mouse as used in (47 (link))], tocilizumab [Actemra from Roche, DIN 02350092; anti-IL-6R at 5 μg/g mouse as used in (48 (link))], anti–IL-3 (aIL3 from Abcam, ab9726; at 2.5 μg/g mouse as recommended by the product sheet], anti–G-CSF (from R&D Systems, MAB414; 10 μg per injection as used in (49 (link))], and anti–GM-CSF (from Abcam, ab9741; at 10 μg/g mouse as recommended by the product sheet] were each administered in 40-μl intraperitoneal doses to separate mice 12 hours before vaccination, at vaccination, and at 24 and 48 hours after vaccination until euthanasia at 72 hours after vaccination for flow cytometry of splenocytes.